Clinically aligned procurement advisory that protects patient outcomes while managing vendor complexity, standards risk, and cost pressures.
Healthcare organizations face a unique intersection of clinical technology complexity, vendor fragmentation, interoperability mandates, and intense cost pressures. Procurement decisions directly impact patient outcomes, clinician workflows, and operational resilience. That requires advisory that understands both the commercial and clinical dimensions, and how to optimize for them.
Align vendor selections and contract structures with clinical workflow requirements, interoperability standards, and patient safety priorities.
Navigate HIPAA, HITECH, and payer-specific compliance requirements that shape vendor evaluation and contract terms.
Drive savings without compromising care quality — balancing financial discipline with clinical needs.
Establish governance frameworks across fragmented EHR, medical device, and clinical SaaS vendor ecosystems.
Support clinical stakeholder alignment, change management, and technology integration across departments and care settings.
Implement governance frameworks calibrated to healthcare compliance cycles and clinical review cadences.
Data-driven refinement aligned with evolving regulatory landscape and clinical technology advancements.
Reduced vendor fragmentation across clinical and administrative systems
Improved total cost of ownership visibility across the healthcare technology portfolio
Explore how Telmac serves Financial Services, Healthcare, and Private Equity.
Technology, sourcing, and governance advisory for investment environments where execution determines returns.
Our team brings direct experience in healthcare technology procurement, including EHR negotiations, medical device contracting, and clinical SaaS governance. We understand HIPAA, interoperability requirements, and the clinical stakeholder dynamics that shape vendor decisions.
Yes — EHR renewals are among our most common healthcare engagements. We bring deep understanding of vendor-specific dynamics, pricing models, and negotiation leverage points unique to major EHR platforms.
We never recommend cost cuts that compromise patient care. Our approach identifies savings in commercial terms, vendor rationalization, and governance efficiency — not in clinical capability reduction.
Yes. While provider organizations represent most of our healthcare engagements, we also work with payer organizations on technology vendor strategy and procurement governance.
Most vendor and technology environments in financial services contain untapped leverage across contracts, spend, and governance. We surface it, structure it, and turn it into lasting control.